Of the 200,000 Americans diagnosed with Acute Respiratory Distress Syndrome (ARDS) each year, 30 to 50 percent will die. But, clinical researchers identified a less-invasive treatment option for patients with severely impaired lung function.
Of the 200,000 Americans diagnosed with Acute Respiratory Distress Syndrome (ARDS) each year, 30 to 50 percent will die. But, clinical researchers identified a less-invasive treatment option for patients with severely impaired lung function.